首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Rational development of high-affinity T-cell receptor-like antibodies
【2h】

Rational development of high-affinity T-cell receptor-like antibodies

机译:高亲和力T细胞受体样抗体的合理开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T-cell interaction with a target cell is a key event in the adaptive immune response and primarily driven by T-cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes. TCR avidity for a given pMHC is determined by number of MHC molecules, availability of coreceptors, and TCR affinity for MHC or peptide, respectively, with peptide recognition being the most important factor to confer target specificity. Here we present high-resolution crystal structures of 2 Fab antibodies in complex with the immunodominant NY-ESO-1157–165 peptide analogue (SLLMWITQV) presented by HLA-A*0201 and compare them with a TCR recognizing the same pMHC. Binding to the central methionine-tryptophan peptide motif and orientation of binding were almost identical for Fabs and TCR. As the MW “peg” dominates the contacts between Fab and peptide, we estimated the contributions of individual amino acids between the Fab and peptide to provide the rational basis for a peptide-focused second-generation, high-affinity antibody library. The final Fab candidate achieved better peptide binding by 2 light-chain mutations, giving a 20-fold affinity improvement to 2–4 nM, exceeding the affinity of the TCR by 1,000-fold. The high-affinity Fab when grafted as recombinant TCR on T cells conferred specific killing of HLA-A*0201/NY-ESO-1157–165 target cells. In summary, we prove that affinity maturation of antibodies mimicking a TCR is possible and provide a strategy for engineering high-affinity antibodies that can be used in targeting specific pMHC complexes for diagnostic and therapeutic purposes.
机译:T细胞与靶细胞的相互作用是适应性免疫反应中的关键事件,并且主要由肽MHC(pMHC)复合物的T细胞受体(TCR)识别驱动。给定pMHC的TCR亲和力分别取决于MHC分子的数量,共受体的可用性以及对MHC或肽的TCR亲和力,其中肽的识别是赋予靶标特异性的最重要因素。在这里,我们介绍由HLA-A * 0201提出的具有免疫优势的NY-ESO-1157-165肽类似物(SLLMWITQV)复杂的2 Fab抗体的高分辨率晶体结构,并将它们与识别相同pMHC的TCR进行比较。对于Fab和TCR,与中央蛋氨酸-色氨酸肽基序的结合和结合方向几乎相同。由于MW“ peg”支配Fab与肽之间的接触,我们估算了Fab与肽之间各个氨基酸的贡献,从而为以肽为重点的第二代高亲和力抗体库提供了合理的基础。最终的Fab候选物通过2个轻链突变实现了更好的肽结合,使亲和力提高了20倍,达到2-4 nM,超过了TCR的亲和力1000倍。高亲和力Fab作为重组TCR移植到T细胞上时,可特异性杀伤HLA-A * 0201 / NY-ESO-1157-165目标细胞。总之,我们证明了模仿TCR的抗体的亲和力成熟是可能的,并提供了一种工程化高亲和力抗体的策略,该抗体可用于靶向特定pMHC复合物以用于诊断和治疗目的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号